1
|
Pålbrink AK, In 't Zandt R, Magnusson M, Degerman E. Betahistine prevents development of endolymphatic hydrops in a mouse model of insulin resistance and diabetes. Acta Otolaryngol 2023; 143:127-133. [PMID: 36735299 DOI: 10.1080/00016489.2023.2171116] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
BACKGROUND Diabetes is associated with inner ear dysfunction. Furthermore, C57BL/6J mice fed high fat diet (HFD), a model for insulin resistance and diabetes, develop endolymphatic hydrops (EH). AIM Evaluate if betahistine, spironolactone (aldosterone antagonist) and empagliflozin (sodium -glucose cotransporter2 inhibitor) can prevent EH induced by HFD and explore potential mechanisms. METHODS C57BL/6J mice fed HFD were treated with respective drug. The size of the endolymphatic fluid compartment was measured using contrast enhanced MRI. Secondarily, mice treated with cilostamide, a phosphodiesterase3 inhibitor, to induce EH and HEI-OC1 auditory cells were used to study potential cellular mechanisms of betahistine. RESULTS HFD-induced EH was prevented by betahistine but not by spironolactone and empagliflozin. Betahistine induced phosphorylation of protein kinaseA substrates but did not prevent cilostamide-induced EH. CONCLUSIONS Betahistine prevents the development of EH in mice fed HFD, most likely not involving pathways downstream of phosphodiesterase3, an enzyme with implications for dysfunction in diabetes. The finding that spironolactone did not prevent HFD-induced EH suggests different mechanisms for EH induction/treatment since spironolactone prevents EH induced by vasopressin, as previously observed. SIGNIFICANCE This further demonstrates that independent mechanisms can cause hydropic inner ear diseases which suggests different therapeutic approaches and emphazises the need for personalized medicine.
Collapse
Affiliation(s)
- Ann-Ki Pålbrink
- Department of Experimental Medical Science, Section for Diabetes, Metabolism and Endocrinology, Lund University Diabetes Centre, Lund, Sweden
| | - René In 't Zandt
- Lund University Bioimaging Center, Lund University, Lund, Sweden
| | - Måns Magnusson
- Department of Clinical Science, Section for Otorhinolaryngology, Lund University & Skåne University Hospital, Lund, Sweden
| | - Eva Degerman
- Department of Experimental Medical Science, Section for Diabetes, Metabolism and Endocrinology, Lund University Diabetes Centre, Lund, Sweden
| |
Collapse
|
2
|
Chen Y, Lu S, Zhang Y, Chen B, Zhou H, Jiang H. Examination of the emerging role of transporters in the assessment of nephrotoxicity. Expert Opin Drug Metab Toxicol 2022; 18:787-804. [PMID: 36420583 DOI: 10.1080/17425255.2022.2151892] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
INTRODUCTION The kidney is vulnerable to various injuries based on its function in the elimination of many xenobiotics, endogenous substances and metabolites. Since transporters are critical for the renal elimination of those substances, it is urgent to understand the emerging role of transporters in nephrotoxicity. AREAS COVERED This review summarizes the contribution of major renal transporters to nephrotoxicity induced by some drugs or toxins; addresses the role of transporter-mediated endogenous metabolic disturbances in nephrotoxicity; and discusses the advantages and disadvantages of in vitro models based on transporter expression and function. EXPERT OPINION Due to the crucial role of transporters in the renal disposition of xenobiotics and endogenous substances, it is necessary to further elucidate their renal transport mechanisms and pay more attention to the underlying relationship between the transport of endogenous substances and nephrotoxicity. Considering the species differences in the expression and function of transporters, and the low expression of transporters in general cell models, in vitro humanized models, such as humanized 3D organoids, shows significant promise in nephrotoxicity prediction and mechanism study.
Collapse
Affiliation(s)
- Yujia Chen
- Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, P.R. China
| | - Shuanghui Lu
- Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, P.R. China
| | - Yingqiong Zhang
- Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, P.R. China.,Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, P.R. China
| | - Binxin Chen
- Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, P.R. China
| | - Hui Zhou
- Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, P.R. China.,Jinhua Institute of Zhejiang University, Jinhua, P.R. China
| | - Huidi Jiang
- Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, P.R. China.,Jinhua Institute of Zhejiang University, Jinhua, P.R. China
| |
Collapse
|
3
|
Dash S, Zuo J, Steyger PS. Local Delivery of Therapeutics to the Cochlea Using Nanoparticles and Other Biomaterials. Pharmaceuticals (Basel) 2022; 15:1115. [PMID: 36145336 PMCID: PMC9504900 DOI: 10.3390/ph15091115] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2022] [Revised: 08/24/2022] [Accepted: 08/31/2022] [Indexed: 11/28/2022] Open
Abstract
Hearing loss negatively impacts the well-being of millions of people worldwide. Systemic delivery of ototherapeutics has limited efficacy due to severe systemic side effects and the presence of the blood-labyrinth barrier that selectively limits or enables transfer of molecules between plasma and inner ear tissues and fluids. Local drug delivery into the middle and inner ear would be preferable for many newly emerging classes of drugs. Although the cochlea is a challenging target for drug delivery, recent technologies could provide a safe and efficacious delivery of ototherapeutics. Local drug delivery routes include topical delivery via the external auditory meatus, retroauricular, transtympanic, and intracochlear delivery. Many new drug delivery systems specifically for the inner ear are under development or undergoing clinical studies. Future studies into these systems may provide a means for extended delivery of drugs to preserve or restore hearing in patients with hearing disorders. This review outlines the anatomy of the (inner) ear, describes the various local delivery systems and routes, and various quantification methodologies to determine the pharmacokinetics of the drugs in the inner ear.
Collapse
Affiliation(s)
| | | | - Peter S. Steyger
- Translational Hearing Center, Department of Biomedical Sciences, Creighton University School of Medicine, 2500 California Plaza, Omaha, NE 68178, USA
| |
Collapse
|
4
|
Koç Ş. A possible follow-up method for diabetic heart failure patients. Int J Clin Pract 2021; 75:e14794. [PMID: 34482595 DOI: 10.1111/ijcp.14794] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/16/2021] [Accepted: 09/02/2021] [Indexed: 11/30/2022] Open
Abstract
INTRODUCTION Plasma osmolarity is maintained through various mechanisms. The osmolarity of the aqueous humor around the crystalline lens is correlated with plasma osmolarity. A vacuole can be formed in the lens upon changes in osmolarity. The sodium-glucose cotransporter 2 inhibitors (SGLT2i) are new in the treatment of heart failure. They can cause osmotic diuresis but do not affect plasma osmolarity. OBJECTIVE It is unclear if the presence or absence of lens vacuole changes can monitor diabetic heart failure and SGLT2i treatment efficacy. METHODS Web of Science, PubMed and Scopus databases were searched for relevant articles about osmolarity, diabetes, transient receptor potential vanilloid channel, diabetic heart failure, lens vacuoles up to May 2021. MAIN MESSAGE The effect of SGLT2i on osmosis underlies its benefit to heart failure, but this in turn affects many other mechanisms. Failure to experience osmolarity changes will reduce the negative changes in terms of heart failure affected by osmolarity. A practical observable method is needed. CONCLUSIONS There is a possibility of using lens vacuoles in the follow-up of diabetic heart failure patients.
Collapse
Affiliation(s)
- Şahbender Koç
- University of Health Sciences, Keçiören Education and Training Hospital, Ankara, Turkey
| |
Collapse
|
5
|
Chai Y, He W, Yang W, Hetrick AP, Gonzalez JG, Sargsyan L, Wu H, Jung TTK, Li H. Intratympanic Lipopolysaccharide Elevates Systemic Fluorescent Gentamicin Uptake in the Cochlea. Laryngoscope 2021; 131:E2573-E2582. [PMID: 33956344 PMCID: PMC8453712 DOI: 10.1002/lary.29610] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/31/2020] [Revised: 04/09/2021] [Accepted: 04/26/2021] [Indexed: 12/20/2022]
Abstract
Objectives/Hypothesis Lipopolysaccharide (LPS), a key component of bacterial endotoxins, activates macrophages and triggers the release of inflammatory cytokines in mammalian tissues. Recent studies have shown that intratympanic injection of LPS simulates acute otitis media (AOM) and results in morphological and functional changes in the inner ear. Here we established an AOM mouse model with LPS to investigate the uptake of ototoxic gentamicin in the inner ear, and elucidated the underlying mechanism by focusing on cochlear inflammation as a result of AOM. Study Design Preclinical rodent animal model. Methods Fluorescently tagged gentamicin (GTTR) was systemically administered to mice with AOM. Iba1‐positive macrophage morphology and inner ear cytokine profile were evaluated by immunofluorescence technique and a mouse cytokine array kit, respectively. Results We observed characteristic symptoms of AOM in the LPS‐treated ears with elevated hearing thresholds indicating a conductive hearing loss. More importantly, the LPS‐induced AOM activated cochlear inflammatory responses, manifested by macrophage infiltration, particularly in the organ of Corti and the spiral ligament, in addition to the up‐regulation of proinflammatory cytokines. Meanwhile, GTTR uptake in the stria vascularis and sensory hair cells from all the LPS‐treated ears was significantly enhanced at 24, 48, and 72‐hour post‐treatment, as the most prominent enhancement was observed in the 48‐hour group. Conclusion In summary, this study suggests that the pathological cochlea is more susceptible to ototoxic drugs, including aminoglycosides, and justified the clinical concern of aminoglycoside ototoxicity in the AOM treatment. Laryngoscope, 131:E2573–E2582, 2021
Collapse
Affiliation(s)
- Yongchuan Chai
- Research Service, VA Loma Linda Healthcare System, Loma Linda, California, U.S.A.,Department of Otolaryngology Head and Neck Surgery, Shanghai Ninth People's Hospital Affiliated Shanghai Jiaotong University School of Medicine, Shanghai, China.,Ear Institute, Shanghai Jiaotong University School of Medicine, Shanghai, China.,Department of Otolaryngology Head and Neck Surgery, Loma Linda University Health, Loma Linda, California, U.S.A
| | - Weiwei He
- Research Service, VA Loma Linda Healthcare System, Loma Linda, California, U.S.A.,Department of Otolaryngology Head and Neck Surgery, Shanghai Ninth People's Hospital Affiliated Shanghai Jiaotong University School of Medicine, Shanghai, China.,Ear Institute, Shanghai Jiaotong University School of Medicine, Shanghai, China.,Department of Otolaryngology Head and Neck Surgery, Loma Linda University Health, Loma Linda, California, U.S.A
| | - Weiqiang Yang
- Research Service, VA Loma Linda Healthcare System, Loma Linda, California, U.S.A.,Department of Otolaryngology Head and Neck Surgery, Loma Linda University Health, Loma Linda, California, U.S.A
| | - Alisa P Hetrick
- Research Service, VA Loma Linda Healthcare System, Loma Linda, California, U.S.A
| | - Jessica G Gonzalez
- Research Service, VA Loma Linda Healthcare System, Loma Linda, California, U.S.A
| | - Liana Sargsyan
- Research Service, VA Loma Linda Healthcare System, Loma Linda, California, U.S.A
| | - Hao Wu
- Department of Otolaryngology Head and Neck Surgery, Shanghai Ninth People's Hospital Affiliated Shanghai Jiaotong University School of Medicine, Shanghai, China.,Ear Institute, Shanghai Jiaotong University School of Medicine, Shanghai, China
| | - Timothy T K Jung
- Research Service, VA Loma Linda Healthcare System, Loma Linda, California, U.S.A.,Department of Otolaryngology Head and Neck Surgery, Loma Linda University Health, Loma Linda, California, U.S.A
| | - Hongzhe Li
- Research Service, VA Loma Linda Healthcare System, Loma Linda, California, U.S.A.,Department of Otolaryngology Head and Neck Surgery, Loma Linda University Health, Loma Linda, California, U.S.A
| |
Collapse
|
6
|
Impact of an SGLT2-loss of function mutation on renal architecture, histology, and glucose homeostasis. Cell Tissue Res 2021; 384:527-543. [PMID: 33409652 DOI: 10.1007/s00441-020-03358-8] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/17/2020] [Accepted: 11/18/2020] [Indexed: 01/14/2023]
Abstract
Inhibitors of sodium/glucose co-transporter 2 (SGLT2) are currently in clinical use for type 2 diabetes (T2D) treatment due to their anti-hyperglycemic effect exerted by the inhibition of glucose reabsorption in the kidney. Inhibition of SGLT2 is associated with improvement of renal outcomes in chronic kidney disease associated with T2D. Our study aimed to describe the renal-specific phenotypic consequences of the SGLT2-loss of function "Jimbee" mutation within the Slc5a2 mouse gene in a non-diabetic/non-obese background. The Jimbee mice displayed reduced body weight, glucosuria, polyuria, polydipsia, and hyperphagia but were normoglycemic, with no signs of baseline insulin resistance or renal dysfunction. Histomorphological analysis of the kidneys revealed a normal architecture and morphology of the renal cortex, but shrinkage of the glomerular and tubular apparatus, including Bowman's space, glomerular tuft, mesangial matrix fraction, and proximal convoluted tubule (PCT). Immunofluorescent analysis of renal sections showed that SGLT2 was absent from the apical membrane of PCT of the Jimbee mice but remnant positive vesicles were detected within the cytosol or at the perinuclear interface. Renal localization and abundance of GLUT1, GLUT2, and SGLT1 were unchanged in the Jimbee genotype. Intriguingly, the mutation did not induce hepatic gluconeogenic gene expression in overnight fasted mice despite a high glucose excretion rate. The Jimbee phenotype is remarkably similar to humans with SLC5A2 mutations and provides a useful model for the study of SGLT2-loss of function effects on renal architecture and physiology, as well as for identifying possible novel roles for the kidneys in glucose homeostasis and metabolic reprogramming.
Collapse
|
7
|
Qian X, He Z, Wang Y, Chen B, Hetrick A, Dai C, Chi F, Li H, Ren D. Hair cell uptake of gentamicin in the developing mouse utricle. J Cell Physiol 2020; 236:5235-5252. [PMID: 33368220 DOI: 10.1002/jcp.30228] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/17/2020] [Revised: 11/27/2020] [Accepted: 12/08/2020] [Indexed: 12/27/2022]
Abstract
Intratympanic injection of gentamicin has proven to be an effective therapy for intractable vestibular dysfunction. However, most studies to date have focused on the cochlea, so little is known about the distribution and uptake of gentamicin by the counterpart of the auditory system, specifically vestibular hair cells (HCs). Here, with a combination of in vivo and in vitro approaches, we used a gentamicin-Texas Red (GTTR) conjugate to investigate the mechanisms of gentamicin vestibulotoxicity in the developing mammalian utricular HCs. In vivo, GTTR fluorescence was concentrated in the apical cytoplasm and the cellular membrane of neonatal utricular HCs, but scarce in the nucleus of HCs and supporting cells. Quantitative analysis showed the GTTR uptake by striolar HCs was significantly higher than that in the extrastriola. In addition, the GTTR fluorescence intensity in the striola was increased gradually from 1 to 8 days, peaking at 8-9 days postnatally. In vitro, utricle explants were incubated with GTTR and candidate uptake conduits, including mechanotransduction (MET) channels and endocytosis in the HC, were inhibited separately. GTTR uptake by HCs could be inhibited by quinine, a blocker of MET channels, under both normal and stressed conditions. Meanwhile, endocytic inhibition only reduced GTTR uptake in the CoCl2 hypoxia model. In sum, the maturation of MET channels mediated uptake of GTTR into vestibular HCs. Under stressed conditions, MET channels play a pronounced role, manifested by channel-dependent stress enhanced GTTR permeation, while endocytosis participates in GTTR entry in a more selective manner.
Collapse
Affiliation(s)
- Xiaoqing Qian
- ENT Institute and Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai, China.,NHC Key Laboratory of Hearing Medicine (Fudan University), Shanghai, China
| | - Ziyu He
- ENT Institute and Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai, China.,NHC Key Laboratory of Hearing Medicine (Fudan University), Shanghai, China
| | - Yanmei Wang
- ENT Institute and Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai, China.,NHC Key Laboratory of Hearing Medicine (Fudan University), Shanghai, China
| | - Binjun Chen
- ENT Institute and Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai, China.,NHC Key Laboratory of Hearing Medicine (Fudan University), Shanghai, China
| | - Alisa Hetrick
- Research Service, VA Loma Linda Healthcare System, Loma Linda, California, USA
| | - Chunfu Dai
- ENT Institute and Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai, China.,NHC Key Laboratory of Hearing Medicine (Fudan University), Shanghai, China
| | - Fanglu Chi
- ENT Institute and Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai, China.,NHC Key Laboratory of Hearing Medicine (Fudan University), Shanghai, China
| | - Hongzhe Li
- Research Service, VA Loma Linda Healthcare System, Loma Linda, California, USA.,Department of Otolaryngology-Head and Neck Surgery, Loma Linda University School of Medicine, Loma Linda, California, USA
| | - Dongdong Ren
- ENT Institute and Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai, China.,NHC Key Laboratory of Hearing Medicine (Fudan University), Shanghai, China
| |
Collapse
|
8
|
Toll-like Receptor 4 Signaling and Downstream Neutrophilic Inflammation Mediate Endotoxemia-Enhanced Blood-Labyrinth Barrier Trafficking. Otol Neurotol 2020; 41:123-132. [PMID: 31568132 DOI: 10.1097/mao.0000000000002447] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
HYPOTHESIS Both toll-like receptor 4 (TLR4) and downstream neutrophil activity are required for endotoxemia-enhanced blood-labyrinth barrier (BLB) trafficking. BACKGROUND Aminoglycoside and cisplatin are valuable clinical therapies; however, these drugs often cause life-long hearing loss. Endotoxemia enhances the ototoxicity of aminoglycosides and cisplatin in a TLR4 dependent mechanism for which downstream proinflammatory signaling orchestrates effector immune cells including neutrophils. Neutrophil-mediated vascular injury (NMVI) can enhance molecular trafficking across endothelial barriers and may contribute to endotoxemia-enhanced drug-induced ototoxicity. METHODS Lipopolysaccharide (LPS) hypo-responsive TLR4-KO mice and congenitally neutropenic granulocyte colony-stimulating factor (GCSF) GCSF-KO mice were studied to investigate the relative contributions of TLR4 signaling and downstream neutrophil activity to endotoxemia-enhanced BLB trafficking. C57Bl/6 wild-type mice were used as a positive control. Mice were treated with LPS and 24 hours later cochleae were analyzed for gene transcription of innate inflammatory cytokine/chemokine signaling molecules, neutrophil recruitment, and vascular trafficking of the paracellular tracer biocytin-TMR. RESULTS Cochlear transcription of innate proinflammatory cytokines/chemokines was increased in endotoxemic C57Bl/6 and GCSF-KO, but not in TLR4-KO mice. More neutrophils were recruited to endotoxemic C57Bl/6 cochleae compared with both TLR4 and GCSF-KO cochleae. Endotoxemia enhanced BLB trafficking of biocytin-TMR in endotoxemic C57Bl/6 cochleae and this was attenuated in both TLR4 and GCSF-KO mice. CONCLUSION Together these results suggest that TLR4-mediated innate immunity cytokine/chemokine signaling alone is not sufficient for endotoxemia-enhanced trafficking of biocytin-TMR and that downstream neutrophil activity is required to enhance BLB trafficking. Clinically, targeting neutrophilic inflammation could protect hearing during aminoglycoside, cisplatin, or other ototoxic drug therapies.
Collapse
|
9
|
Song Z, Zhu J, Wei Q, Dong G, Dong Z. Canagliflozin reduces cisplatin uptake and activates Akt to protect against cisplatin-induced nephrotoxicity. Am J Physiol Renal Physiol 2020; 318:F1041-F1052. [PMID: 32150448 DOI: 10.1152/ajprenal.00512.2019] [Citation(s) in RCA: 26] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023] Open
Abstract
Cisplatin is a widely used chemotherapy drug with notorious nephrotoxicity. Na+-glucose cotransporter 2 inhibitors are a class of novel antidiabetic agents that may have other effects in the kidneys besides blood glucose control. In the present study, we demonstrated that canagliflozin significantly attenuates cisplatin-induced nephropathy in C57BL/6 mice and suppresses cisplatin induced renal proximal tubular cell apoptosis in vitro. The protective effect of canagliflozin was associated with inhibition of p53, p38 and JNK activation. Mechanistically, canagliflozin partially reduced cisplatin uptake by kidney tissues in mice and renal tubular cells in culture. In addition, canagliflozin enhanced the activation of Akt and inhibited the mitochondrial pathway of apoptosis during cisplatin treatment. The protective effect of canagliflozin was diminished by the phosphatidylinositol 3-kinase/Akt inhibitor LY294002. Notably, canagliflozin did not affect the chemotherapeutic efficacy of cisplatin in A549 and HCT116 cancer cell lines. These results suggest a new application of canagliflozin for renoprotection in cisplatin chemotherapy. Canagliflozin may protect kidneys by reducing cisplatin uptake and activating cell survival pathways.
Collapse
Affiliation(s)
- Zhixia Song
- Department of Nephrology, Central People's Hospital of Yichang, The First Clinical Medical College of Three Gorges University, Yichang, China.,Department of Cellular Biology and Anatomy, Medical College of Georgia, Augusta University, Augusta, Georgia.,Charlie Norwood Veterans Affairs Medical Center, Augusta, Georgia
| | - Jiefu Zhu
- Department of Cellular Biology and Anatomy, Medical College of Georgia, Augusta University, Augusta, Georgia.,Charlie Norwood Veterans Affairs Medical Center, Augusta, Georgia.,Department of Nephrology, The Second Xiangya Hospital, Central South University, Changsha, China
| | - Qingqing Wei
- Department of Cellular Biology and Anatomy, Medical College of Georgia, Augusta University, Augusta, Georgia.,Charlie Norwood Veterans Affairs Medical Center, Augusta, Georgia
| | - Guie Dong
- Department of Cellular Biology and Anatomy, Medical College of Georgia, Augusta University, Augusta, Georgia.,Charlie Norwood Veterans Affairs Medical Center, Augusta, Georgia
| | - Zheng Dong
- Department of Cellular Biology and Anatomy, Medical College of Georgia, Augusta University, Augusta, Georgia.,Charlie Norwood Veterans Affairs Medical Center, Augusta, Georgia
| |
Collapse
|
10
|
Jiang M, Li H, Johnson A, Karasawa T, Zhang Y, Meier WB, Taghizadeh F, Kachelmeier A, Steyger PS. Inflammation up-regulates cochlear expression of TRPV1 to potentiate drug-induced hearing loss. SCIENCE ADVANCES 2019; 5:eaaw1836. [PMID: 31328162 PMCID: PMC6636990 DOI: 10.1126/sciadv.aaw1836] [Citation(s) in RCA: 37] [Impact Index Per Article: 7.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/26/2018] [Accepted: 06/13/2019] [Indexed: 05/26/2023]
Abstract
Aminoglycoside antibiotics are essential for treating life-threatening bacterial infections, despite the risk of lifelong hearing loss. Infections induce inflammation and up-regulate expression of candidate aminoglycoside-permeant cation channels, including transient receptor potential vanilloid-1 (TRPV1). Heterologous expression of TRPV1 facilitated cellular uptake of (fluorescently tagged) gentamicin that was enhanced by agonists, and diminished by antagonists, of TRPV1. Cochlear TRPV1 was immunolocalized near the apical membranes of sensory hair cells, adjacent supporting cells, and marginal cells in the stria vascularis. Exposure to immunostimulatory lipopolysaccharides, to simulate of bacterial infections, increased cochlear expression of TRPV1 and hair cell uptake of gentamicin. Lipopolysaccharide exposure exacerbated aminoglycoside-induced auditory threshold shifts and loss of cochlear hair cells in wild-type, but not in heterozygous Trpv1+/- or Trpv1 knockout, mice. Thus, TRPV1 facilitates cochlear uptake of aminoglycosides, and bacteriogenic stimulation upregulates TRPV1 expression to exacerbate cochleotoxicity. Furthermore, loss-of-function polymorphisms in Trpv1 can protect against immunogenic exacerbation of aminoglycoside-induced cochleotoxicity.
Collapse
Affiliation(s)
- Meiyan Jiang
- Oregon Hearing Research Center, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA
| | - Hongzhe Li
- Oregon Hearing Research Center, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA
| | - Anastasiya Johnson
- Oregon Hearing Research Center, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA
| | - Takatoshi Karasawa
- Oregon Hearing Research Center, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA
| | - Yuan Zhang
- Oregon Hearing Research Center, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA
| | - William B. Meier
- Oregon Hearing Research Center, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA
| | - Farshid Taghizadeh
- Oregon Hearing Research Center, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA
| | - Allan Kachelmeier
- Oregon Hearing Research Center, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA
| | - Peter S. Steyger
- Oregon Hearing Research Center, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA
- National Center for Rehabilitative Auditory Research, VA Portland Health Care System, Portland, OR 97239, USA
| |
Collapse
|
11
|
Gayen A, Kumar D, Matheshwaran S, Chandra M. Unveiling the Modulating Role of Extracellular pH in Permeation and Accumulation of Small Molecules in Subcellular Compartments of Gram-negative Escherichia coli using Nonlinear Spectroscopy. Anal Chem 2019; 91:7662-7671. [PMID: 30986344 DOI: 10.1021/acs.analchem.9b00574] [Citation(s) in RCA: 17] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Abstract
Quantitative evaluation of small molecule permeation and accumulation in Gram-negative bacteria is important for drug development against these bacteria. While these measurements are commonly performed at physiological pH, Escherichia coli and many other Enterobacteriaceae infect human gastrointestinal and urinary tracts, where they encounter different pH conditions. To understand how external pH affects permeation and accumulation of small molecules in E. coli cells, we apply second harmonic generation (SHG) spectroscopy using SHG-active antimicrobial compound malachite green as the probe molecule. Using SHG, we quantify periplasmic and cytoplasmic accumulations separately in live E. coli cells, which was never done before. Compartment-wise measurements reveal accumulation of the probe molecule in cytoplasm at physiological and alkaline pH, while entrapment in periplasm at weakly acidic pH and retention in external solution at highly acidic pH. Behind such disparity in localizations, up to 2 orders of magnitude reduction in permeability across the inner membrane at weakly acidic pH and outer membrane at highly acidic pH are found to play key roles. Our results unequivocally demonstrate the control of external pH over entry and compartment-wise distribution of small molecules in E. coli cells, which is a vital information and should be taken into account in antibiotic screening against E. coli and other Enterobacteriaceae members. In addition, our results demonstrate the ability of malachite green as an excellent SHG-indicator of changes of individual cell membrane and periplasm properties of live E. coli cells in response to external pH change from acidic to alkaline. This finding, too, has great importance, as there is barely any other molecular probe that can provide similar information.
Collapse
|
12
|
Yamada K. Aberrant Uptake of a Fluorescent L-Glucose Analogue (fLG) into Tumor Cells Expressing Malignant Phenotypes. Biol Pharm Bull 2019; 41:1508-1516. [PMID: 30270319 DOI: 10.1248/bpb.b18-00089] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Glucose, one of the most fundamental sugar elements, has either D- or L-conformation. Of these, most cells preferentially take up D-glucose as an essential energy/carbon source. Such stereoselective uptake of glucose has been explored by fluorophore-bearing D- and L-glucose analogues. 2-[N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl)amino]-2-deoxy-D-glucose (2-NBDG), the most widely used fluorescent D-glucose analogue, was abundantly taken up into living Escherichia coli cells, whereas no detectable uptake was obtained for 2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino]-2-deoxy-L-glucose (2-NBDLG), the antipode of 2-NBDG developed as a fluorescent L-glucose analogue (fLG). Interestingly, we found three-dimensionally accumulating tumor cell aggregates taking up 2-NBDLG when they expressed nuclear heterogeneity, one of the major cytological criteria for cells suspected of high-grade malignancy in clinical diagnosis. 2-NBDLG uptake was not detected in aggregates consisting of homogeneous cells and was specifically abolished by phloretin, a broad-spectrum inhibitor against transporters/channels. Preliminary studies have suggested that a combined use of 2-NBDLG, which emits green fluorescence, with 13-[4-[(2-deoxy-D-glucopyranose-2-yl)aminosulfonyl]-2-sulfonatophenyl]-4,5-trimethylene-7,8-trimethylene-1,2,3,4,6,9,10,11-octahydro-4-aza-6-oxa-8-azoniapentacene (2-TRLG), a membrane-impermeable fLG bearing a large red fluorophore, is effective for discriminating malignant tumor from benign cells both in living biopsy specimens endoscopically dissected from patients with early-stage gastric cancer and in ascites fluid of patients with gynecological cancers. Confocal endomicroscopic imaging of a carcinogen-induced cancer in bile duct of hamsters indicated that the fLG uptake pattern well correlated with pathological diagnosis for carcinoma. Safety tests according to Good Laboratory Practice regulations have been successfully completed so far. fLGs are unique fluorescent glucose analogues for identifying and characterizing living cancer cells based on derangements in their transport function.
Collapse
Affiliation(s)
- Katsuya Yamada
- Department of Physiology, Hirosaki University Graduate School of Medicine
| |
Collapse
|
13
|
Takesue H, Hirota T, Tachimura M, Tokashiki A, Ieiri I. Nucleosome Positioning and Gene Regulation of the SGLT2 Gene in the Renal Proximal Tubular Epithelial Cells. Mol Pharmacol 2018; 94:953-962. [DOI: 10.1124/mol.118.111807] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2018] [Accepted: 06/27/2018] [Indexed: 11/22/2022] Open
|
14
|
Álvarez-Cilleros D, Martín MÁ, Ramos S. (-)-Epicatechin and the Colonic 2,3-Dihydroxybenzoic Acid Metabolite Regulate Glucose Uptake, Glucose Production, and Improve Insulin Signaling in Renal NRK-52E Cells. Mol Nutr Food Res 2018; 62. [PMID: 29205863 DOI: 10.1002/mnfr.201700470] [Citation(s) in RCA: 30] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2017] [Revised: 11/03/2017] [Indexed: 12/16/2022]
Abstract
SCOPE (-)-Epicatechin (EC) and main colonic phenolic acids derived from flavonoid intake, such as 2,3-dihydroxybenzoic acid (DHBA), 3,4-dihydroxyphenylacetic acid (DHPAA), 3-hydroxyphenylpropionic acid (HPPA), and vanillic acid (VA), have been suggested to exert beneficial effects in diabetes, although the mechanism for their actions remains unknown. In this study, the modulation of glucose homeostasis and insulin signaling by the mentioned compounds on renal proximal tubular NRK-52E cells is investigated. METHODS AND RESULTS Levels of the glucose transporters SGLT-2 and GLUT-2, as well as glucose uptake, glucose production, and key proteins of the insulin pathways, namely insulin receptor (IR), insulin receptor substrate-1 (IRS-1), and PI3K/AKT pathway are analyzed. EC (5-20 μm) and DHBA (20 μm) reduced both renal glucose uptake and production. Interestingly, EC and DHBA did not modify the levels of SGLT-2 and GLUT-2, and modulated the expression of phosphoenolpyruvate carboxykinase via AKT leading to a diminished glucose production. EC and DHBA also enhanced the tyrosine phosphorylation and total IR and IRS-1 levels, and activated the PI3K/AKT pathway in NRK-52E cells. CONCLUSION EC and DHBA regulate the renal glucose homeostasis by modulating both glucose uptake and production, and strengthen the insulin signaling by activating key proteins of that pathway in NRK-52E cells.
Collapse
Affiliation(s)
- David Álvarez-Cilleros
- Department of Metabolism and Nutrition, Institute of Food Science and Technology and Nutrition (ICTAN), Consejo Superior de Investigaciones Científicas (CSIC), José Antonio Novais 10, Ciudad Universitaria, Madrid, Spain
| | - María Ángeles Martín
- Department of Metabolism and Nutrition, Institute of Food Science and Technology and Nutrition (ICTAN), Consejo Superior de Investigaciones Científicas (CSIC), José Antonio Novais 10, Ciudad Universitaria, Madrid, Spain.,Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), ISCIII, Spain
| | - Sonia Ramos
- Department of Metabolism and Nutrition, Institute of Food Science and Technology and Nutrition (ICTAN), Consejo Superior de Investigaciones Científicas (CSIC), José Antonio Novais 10, Ciudad Universitaria, Madrid, Spain
| |
Collapse
|
15
|
Jiang M, Karasawa T, Steyger PS. Aminoglycoside-Induced Cochleotoxicity: A Review. Front Cell Neurosci 2017; 11:308. [PMID: 29062271 PMCID: PMC5640705 DOI: 10.3389/fncel.2017.00308] [Citation(s) in RCA: 171] [Impact Index Per Article: 24.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2017] [Accepted: 09/15/2017] [Indexed: 12/20/2022] Open
Abstract
Aminoglycoside antibiotics are used as prophylaxis, or urgent treatment, for many life-threatening bacterial infections, including tuberculosis, sepsis, respiratory infections in cystic fibrosis, complex urinary tract infections and endocarditis. Although aminoglycosides are clinically-essential antibiotics, the mechanisms underlying their selective toxicity to the kidney and inner ear continue to be unraveled despite more than 70 years of investigation. The following mechanisms each contribute to aminoglycoside-induced toxicity after systemic administration: (1) drug trafficking across endothelial and epithelial barrier layers; (2) sensory cell uptake of these drugs; and (3) disruption of intracellular physiological pathways. Specific factors can increase the risk of drug-induced toxicity, including sustained exposure to higher levels of ambient sound, and selected therapeutic agents such as loop diuretics and glycopeptides. Serious bacterial infections (requiring life-saving aminoglycoside treatment) induce systemic inflammatory responses that also potentiate the degree of ototoxicity and permanent hearing loss. We discuss prospective clinical strategies to protect auditory and vestibular function from aminoglycoside ototoxicity, including reduced cochlear or sensory cell uptake of aminoglycosides, and otoprotection by ameliorating intracellular cytotoxicity.
Collapse
Affiliation(s)
- Meiyan Jiang
- Oregon Hearing Research Center, Oregon Health & Science University, Portland, OR, United States
| | - Takatoshi Karasawa
- Oregon Hearing Research Center, Oregon Health & Science University, Portland, OR, United States
| | - Peter S Steyger
- Oregon Hearing Research Center, Oregon Health & Science University, Portland, OR, United States.,National Center for Rehabilitative Auditory Research, Portland VA Medical Center (VHA), Portland, OR, United States
| |
Collapse
|
16
|
Zhang H, Wang G, Yin R, Qiu M, Xu L. [Comprehensive Identification of MicroRNAs Regulated by Long Non-coding RNA MALAT1]. ZHONGGUO FEI AI ZA ZHI = CHINESE JOURNAL OF LUNG CANCER 2017; 19:247-51. [PMID: 27215451 PMCID: PMC5973056 DOI: 10.3779/j.issn.1009-3419.2016.05.11] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Abstract
BACKGROUND Long non-coding RNA (lncRNA) plays important regulatory roles in the development and invasion of various cancers. The aim of current study is to comprehensively identify microRNAs (miRNA) regulated by lncRNA MALAT1 via experimental and bioinformatics methods. METHODS Antisense oligonucleotides (ASO) specifically targeting MALAT1 were designed and synthesized. After knockdown of MALAT1 by ASO in A549 cells, miRNA expression changes were profiled by TqaMan Low Density Array (TLDA). Gene set enrichment analysis (GSEA) was used to search enriched miRNAs among differentially expressed genes after knockdown of MALAT1. RESULTS After efficient knockdown of MALAT1 by ASO, 153 miRNAs were differentially expressed, 131 up-regulated and 22 down-regulated. Among the 458 differentially expressed genes after MALAT1 silence, GSEA results revealed lots of enriched miRNAs. There were 28 overlapped miRNAs between TLDA and GSEA results, suggesting these 28 miRNAs are regulated by MALAT1. CONCLUSIONS This study comprehensively identified MALAT1 regulated miRNAs, providing resources for further research.
Collapse
Affiliation(s)
- Haitian Zhang
- Department of Clinical Medicine, Xuzhou Medical University, Xuzhou 221004, China
| | - Guoxiang Wang
- Department of Cardiothoracic Surgery, Affiliated Hospital of Xuzhou Medical University, Xuzhou 221000, China
| | - Rong Yin
- Department of Thoracic Surgery, Nanjing Medical University Affiliated Cancer Hospital, Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Cancer Institute of Jiangsu Province, Nanjing 210009, China
| | - Mantang Qiu
- Department of Thoracic Surgery, Nanjing Medical University Affiliated Cancer Hospital, Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Cancer Institute of Jiangsu Province, Nanjing 210009, China
| | - Lin Xu
- Department of Thoracic Surgery, Nanjing Medical University Affiliated Cancer Hospital, Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Cancer Institute of Jiangsu Province, Nanjing 210009, China
| |
Collapse
|
17
|
Xu L, Wang Y, Liu Q, Luo H, Zhong X, Li Y. [Role of Autophagy in the Radiosensitivity of Human Lung Adenocarcinoma A549 Cells]. ZHONGGUO FEI AI ZA ZHI = CHINESE JOURNAL OF LUNG CANCER 2017; 19:799-804. [PMID: 27978864 PMCID: PMC5973450 DOI: 10.3779/j.issn.1009-3419.2016.12.01] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
背景与目的 放射治疗是肺癌最重要的治疗手段之一,然而却因放疗抵抗极易导致肿瘤的复发和转移。放疗可诱导肿瘤细胞自噬发生,最新研究也报道,自噬可能与DNA损伤修复过程相关。本研究旨在探讨通过雷帕霉素上调A549细胞自噬,能否增加细胞放疗敏感性,其过程是否与DNA损伤修复过程相关。 方法 以人肺腺癌A549细胞作为实验对象,实验设对照组(N)、单纯放疗组(IR)、雷帕霉素联合放疗组(R+RAPA)。采用Western blot检测γ-H2AX蛋白质、Rad51蛋白质、Ku70/80蛋白质、p62蛋白质、LC3蛋白质表达;电镜检测自噬体形成;细胞克隆形成实验检测细胞存活分数(survival fraction, SF)值。 结果 与单纯放疗组相比,放疗联合雷帕霉素组自噬活性增加,且Rad51、Ku80蛋白质表达减少,细胞增殖能力下降。 结论 通过雷帕霉素上调自噬可增加肺癌细胞放疗敏感性,其机制可能与抑制DNA损伤修复过程相关。
Collapse
Affiliation(s)
- Liyao Xu
- Department of Oncology, the First Affiliated Hospital of Nanchang University, Nanchang 330006, China
| | - Yong Wang
- Department of Oncology, the First Affiliated Hospital of Nanchang University, Nanchang 330006, China
| | - Qin Liu
- Department of Respirology, the First Affiliated Hospital of Nanchang University, Nanchang 330006, China
| | - Hui Luo
- Department of Oncology, the First Affiliated Hospital of Nanchang University, Nanchang 330006, China
| | - Xiaojun Zhong
- Department of Oncology, the First Affiliated Hospital of Nanchang University, Nanchang 330006, China
| | - Yong Li
- Department of Oncology, the First Affiliated Hospital of Nanchang University, Nanchang 330006, China
| |
Collapse
|
18
|
Lian H, Ding Z, Yuan D, Ma J, Qin J. [Diagnostic Value of Folate Receptor-positive Circulating Tumor Cell in Lung Cancer: A Pilot Study]. ZHONGGUO FEI AI ZA ZHI = CHINESE JOURNAL OF LUNG CANCER 2017; 19:813-820. [PMID: 27978866 PMCID: PMC5973455 DOI: 10.3779/j.issn.1009-3419.2016.12.03] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
Abstract
背景与目的 评价一种通过叶酸受体(folate receptor, FR)检测循环肿瘤细胞(circulating tumor cell, CTC)的方法用于肺癌临床诊断的实用性和可行性及进一步探究CTC在肺癌术后复发的预测价值。 方法 通过免疫磁珠负向富集方法从3 mL外周血中捕获循环肿瘤细胞,再用肿瘤特异性叶酸配体-寡核苷酸偶和物标记捕获的循环肿瘤细胞,洗去没有结合的偶和物后,洗脱下特异性结合的偶合物的寡核苷酸用于定量PCR扩增分析。 结果 97例肺癌患者的CTC水平高于肺部良性疾病患者(P < 0.001)。本检测方法以8.7 Folate Units/3 mL为cutoff值,结果显示靶向PCR法对肺癌的检测灵敏度为82.5%,特异性为72.2%,特别是在Ⅰ期肺癌灵敏度达到86.8%。与其他肿瘤标志物(NSE、CEA、CYFRA21-1)比较,CTC对肺癌及Ⅰ期肺癌具有较高的诊断准确性(0.859; 95%CI: 0.779-0.939)和(0.912; 95%CI: 0.829-0.994)。5例肺癌患者术后2周内CTC水平高于cutoff值。 结论 叶酸受体阳性循环肿瘤细胞可以应用于肺癌的临床诊断,即使是对早期非小细胞肺癌(non-small cell lung cancer, NSCLC)的诊断。
Collapse
Affiliation(s)
- Huanhuan Lian
- Department of Thoracic Surgery, Henan Oncology Hospital, Zhengzhou 450008, China
| | - Zhidan Ding
- Department of Thoracic Surgery, Henan Oncology Hospital, Zhengzhou 450008, China
| | - Dongfeng Yuan
- Department of Thoracic Surgery, Henan Oncology Hospital, Zhengzhou 450008, China
| | - Jie Ma
- Department of Molecular Pathology Center, Henan Oncology Hospital, Zhengzhou 450008, China
| | - Jianjun Qin
- Department of Thoracic Surgery, Henan Oncology Hospital, Zhengzhou 450008, China
| |
Collapse
|
19
|
Hailey DW, Esterberg R, Linbo TH, Rubel EW, Raible DW. Fluorescent aminoglycosides reveal intracellular trafficking routes in mechanosensory hair cells. J Clin Invest 2016; 127:472-486. [PMID: 27991862 DOI: 10.1172/jci85052] [Citation(s) in RCA: 56] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2015] [Accepted: 11/03/2016] [Indexed: 11/17/2022] Open
Abstract
Aminoglycosides (AGs) are broad-spectrum antibiotics that are associated with kidney damage, balance disorders, and permanent hearing loss. This damage occurs primarily by killing of proximal tubule kidney cells and mechanosensory hair cells, though the mechanisms underlying cell death are not clear. Imaging molecules of interest in living cells can elucidate how molecules enter cells, traverse intracellular compartments, and interact with sites of activity. Here, we have imaged fluorescently labeled AGs in live zebrafish mechanosensory hair cells. We determined that AGs enter hair cells via both nonendocytic and endocytic pathways. Both routes deliver AGs from the extracellular space to lysosomes, and structural differences between AGs alter the efficiency of this delivery. AGs with slower delivery to lysosomes were immediately toxic to hair cells, and impeding lysosome delivery increased AG-induced death. Therefore, pro-death cascades induced at early time points of AG exposure do not appear to derive from the lysosome. Our findings help clarify how AGs induce hair cell death and reveal properties that predict toxicity. Establishing signatures for AG toxicity may enable more efficient evaluation of AG treatment paradigms and structural modifications to reduce hair cell damage. Further, this work demonstrates how following fluorescently labeled drugs at high resolution in living cells can reveal important details about how drugs of interest behave.
Collapse
|
20
|
Wu W, Zhang S, Hu C. [M3 Muscarnic Receptor Antagonist Mediates Cell Proliferation Apoptosis
and Adhesion in Small Cell Lung Cancer]. ZHONGGUO FEI AI ZA ZHI = CHINESE JOURNAL OF LUNG CANCER 2016; 19:113-21. [PMID: 27009814 PMCID: PMC5999821 DOI: 10.3779/j.issn.1009-3419.2016.03.01] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 12/05/2022]
Abstract
背景与目的 研究表明毒蕈碱胆碱受体3(muscarinic receptor 3, M3R)在多种肿瘤的发生、发展中发挥重要的作用。本研究旨在探讨M3R在人小细胞肺癌(small cell lung cancer, SCLC)细胞株SBC3的表达,M3R拮抗剂对细胞增殖、凋亡及粘附的影响。 方法 体外培养SBC3细胞,RT-PCR和Western blot检测M3R的表达。MTT法及流式细胞法检测M3R拮抗剂(4-diphenylacetoxy-N-methylpiperidine methiodide, 4-DAMP)对细胞增殖和凋亡的影响。流式细胞法检测细胞整合素的表达及碘化乙酰胆碱(acetylcholine iodide, Ach)和4-DAMP对整合素表达的影响。纤维结合蛋白(Fn)包被的96孔板用以研究Ach、4-DAMP及整合素抗体对细胞粘附的作用。 结果 SBC3细胞表达M3R,4-DAMP浓度依懒性抑制细胞增殖。与对照组比较,10-4 M 4-DAMP能够明显地增加SBC3细胞凋亡。SBC3细胞表达αvβ1和α5β1整合素,10-4 M Ach刺激细胞粘附(P<0.01)的作用几乎被10-5 M 4-DAMP、5 μg/mL抗-β1抗体或抗-αv和α5抗体完全阻断(P<0.01),但Ach及4-DAMP不影响αv、α5和β1的表达水平。 结论 SBC3细胞表达M3R,M3R拮抗剂能抑制细胞的增殖并促进凋亡。其抑制粘附的作用是通过抑制细胞含β1的整合素(αvβ1和α5β1)的功能实现的。
Collapse
Affiliation(s)
- Wenting Wu
- Ningxia Medical University Yinchuan 750004, China
| | - Shuxiang Zhang
- Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Ningxia Medical University, Yinchuan 750004, China
| | - Caihong Hu
- Ningxia Medical University Yinchuan 750004, China
| |
Collapse
|
21
|
Chen L, Yang S, Jiang J, Zhang Y, Feng H, Cao J, Ge X, Xie W. [Clinical Assessment of Chemosensitivity Test in Xeno-free Culture of Autologous
Malignant Effusion Cells from Patients with Advanced Lung Adenocarcinoma]. ZHONGGUO FEI AI ZA ZHI = CHINESE JOURNAL OF LUNG CANCER 2016; 19:584-9. [PMID: 27666547 PMCID: PMC5972961 DOI: 10.3779/j.issn.1009-3419.2016.09.04] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
背景与目的 晚期肺癌的化疗效果存在极大的个体差异,如何选择最佳化疗方案,实现肺癌化疗的个体化、效果最大化是值得探索的课题。本研究旨在检验自体积液中进行癌细胞培养及药敏试验对于合并胸腔或心包积液的肺腺癌患者优化化疗方案的临床应用价值。 方法 收集50例并发恶性胸腔和/或心包积液的肺腺癌初治患者,经闭式引流控制积液。其中25例(药敏组)于无菌条件下留取积液300 mL-500 mL,肿瘤细胞通过自体积液(xeno-free)平均11天的细胞培养而获得,继而针对8种临床常用化疗药物行药敏试验,通过CCK-8进行敏感性检测,根据试验结果选择最优化疗方案进行全身化疗;另25例(对照组)进行经验性化疗。 结果 4个周期化疗后,药敏组部分缓解(partial response, PR)17例(68.0%)、稳定(stable disease, SD)5例(20.0%),客观缓解率(objective response rate, ORR)68.0%,疾病控制率(disease control rate, DCR)88.0%;对照组PR 9例(36.0%)、SD 7例(28.0%),ORR为36.0%,DCR为64.0%。比较两组ORR和DCR,差异均有统计学意义(P < 0.05)。至随访截止,药敏组死亡21例,对照组死亡22例。药敏组无进展生存期(progression-free survival, PFS)平均10.0个月,总生存期(overall survival, OS)平均30.2个月;对照组PFS平均5.8个月,OS平均21.2个月。比较两组PFS和OS,差异均有统计学意义(P < 0.05)。两组毒副反应轻微、可控。 结论 自体积液癌细胞培养及药敏试验有利于晚期肺腺癌患者化疗方案的合理选择。
Collapse
Affiliation(s)
- Liang Chen
- Department of Emergency, Shanghai Chest Hospital,
Shanghai Jiaotong University, Shanghai 200030, China
| | - Shunfang Yang
- Department of Nuclear Medicine, Shanghai Chest Hospital,
Shanghai Jiaotong University, Shanghai 200030, China
| | - Jinqi Jiang
- Department of Emergency, Shanghai Chest Hospital,
Shanghai Jiaotong University, Shanghai 200030, China
| | - Ying Zhang
- Department of Emergency, Shanghai Chest Hospital,
Shanghai Jiaotong University, Shanghai 200030, China
| | - Hui Feng
- Department of Emergency, Shanghai Chest Hospital,
Shanghai Jiaotong University, Shanghai 200030, China
| | - Jie Cao
- Department of Nuclear Medicine, Shanghai Chest Hospital,
Shanghai Jiaotong University, Shanghai 200030, China
| | - Xinyue Ge
- Department of Laboratory, Shanghai Chest Hospital,
Shanghai Jiaotong University, Shanghai 200030, China
| | - Wenhui Xie
- Department of Nuclear Medicine, Shanghai Chest Hospital,
Shanghai Jiaotong University, Shanghai 200030, China
| |
Collapse
|
22
|
Liu C, Li Y, Dong Y, Zhang H, Li Y, Liu H, Chen J. [Methylation Status of the SOCS3 Gene Promoter in H2228 Cells and
EML4-ALK-positive Lung Cancer Tissues]. ZHONGGUO FEI AI ZA ZHI = CHINESE JOURNAL OF LUNG CANCER 2016; 19:565-70. [PMID: 27666544 PMCID: PMC5972959 DOI: 10.3779/j.issn.1009-3419.2016.09.01] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
BACKGROUND The EML4-ALK fusion gene is a newly discovered driver gene of non-small cell lung cancer and exhibits special clinical and pathological features. The JAK-STAT signaling pathway, an important downstream signaling pathway of EML4-ALK, is aberrantly sustained and activated in EML4-ALK-positive lung cancer cells fusion gene, but the underlying reason remains unknown. The suppressor of cytokine signaling (SOCS) is a negative regulatory factor that mainly inhibits the proliferation, differentiation, and induction of apoptotic cells by inhibiting the JAK-STAT signaling pathway. The aberrant methylation of the SOCS gene leads to inactivation of tumors and abnormal activation of the JAK2-STAT signaling pathway. The aim of this study is to investigate the methylation status of the SOCS3 promoter in EML4-ALK-positive H2228 cells and lung cancer tissues. METHODS The methylation status of the SOCS3 promoter in EML4-ALK-positive H2228 lung cancer cells and lung cancer tissues was detected by methylation-specific PCR (MSP) analysis and verified by DNA sequencing. The expression levels of SOCS3 in H2228 cells were detected by Western blot and Real-time PCR analyses after treatment with the DNA methyltransferase inhibitor 5'-Aza-dC. RESULTS MSP and DNA sequencing assay results indicated the presence of SOCS3 promoter methylation in H2228 cells as well as in three cases of seven EML4-ALK-positive lung cancer tissues. The expression level of SOCS3 significantly increased in H2228 cells after 5'-Aza-dC treatment. CONCLUSIONS The aerrant methylation of the SOCS3 promoter region in EML4-ALK (+) H2228 cells and lung cancer tissues may be significantly involved in the pathogenesis of EML4-ALK-positive lung cancer.
Collapse
Affiliation(s)
- Chunlai Liu
- Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin 300052, China
| | - Yongwen Li
- Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin 300052, China
| | - Yunlong Dong
- Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin 300052, China
| | - Hongbing Zhang
- Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin 300052, China
| | - Ying Li
- Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin 300052, China
| | - Hongyu Liu
- Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin 300052, China
| | - Jun Chen
- Department of Lung Cancer Surgery;Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin 300052, China
| |
Collapse
|
23
|
Lin G, Huang C, Su G, Hu H, Xu H, Huang C. [Effect of TRAF6 Downregulation on Malignant Biological Behavior of
Lung Cancer Cell Lines]. ZHONGGUO FEI AI ZA ZHI = CHINESE JOURNAL OF LUNG CANCER 2016; 18:661-7. [PMID: 26582220 PMCID: PMC6000311 DOI: 10.3779/j.issn.1009-3419.2015.11.01] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
背景与目的 已有的研究提示肿瘤坏死因子受体相关因子6(tumor necrosis factor receptor-associated factor 6, TRAF6)在肺癌中常常扩增,可能扮演癌基因角色,但TRAF6的确切作用尚未充分阐明。本研究探索TRAF6表达对肺癌细胞株的增殖、凋亡、细胞周期、迁移及侵袭能力的影响以及可能作用机制。 方法 选用A549、H1650、SPC-A-1以及Calu-3等四种肺癌细胞株,应用蛋白印迹、qRT-PCR检测其TRAF6蛋白及mRNA表达。SPC-A-1、Calu-3细胞转染TRAF6 siRNA,以EMSA方法检测不同处理组核因子-κB的DNA结合活性,MTS法检测细胞增殖,流式细胞仪PI染色检测细胞凋亡,流式细胞仪进行细胞周期测定,划痕实验及Transwell小室法检测细胞迁移及侵袭能力,并应用蛋白印迹检测泛素化抗体、p65、CD24、CXCR4等蛋白表达。SPC-A-1细胞提取DNA后,应用二代测序法进行全基因组测序。 结果 在四种细胞株中,SPC-A-1和Calu-3细胞TRAF6相对高表达,TRAF6发生自身K63-泛素化,但仅在SPC-A-1细胞中观察到核因子-κB组成性活化。转染TRAF6 siRNA后,SPC-A-1、Calu-3细胞TRAF6表达明显下调,与空白组及对照组相比,下调TRAF6表达可抑制SPC-A-1细胞核因子-κB活性、降低迁移及侵袭能力以及促进细胞凋亡,CD24和CXCR4的表达也明显下调,但对细胞增殖及细胞周期无明显影响。下调TRAF6表达对Calu-3细胞株的核因子-κB活性、细胞增殖、凋亡、细胞周期、迁移及侵袭能力等均无明显影响。未发现SPC-A-1细胞株TRAF6基因突变或拷贝数改变。 结论 下调TRAF6表达可抑制SPC-A-1细胞迁移及侵袭能力,促进细胞凋亡,并且TRAF6可能是通过调控核因子-κB-CD24/CXCR4信号通路参与调控肺癌侵袭、细胞凋亡。
Collapse
Affiliation(s)
- Gen Lin
- Department of Medical Oncology, Fujian Provincial Cancer Hospital, Fujian Medical University Teaching Hospital, Fuzhou 350014, China
| | - Chuangzhong Huang
- Department of Medical Oncology, Fujian Provincial Cancer Hospital, Fujian Medical University Teaching Hospital, Fuzhou 350014, China
| | - Guangjian Su
- Department of Medical Oncology, Fujian Provincial Cancer Hospital, Fujian Medical University Teaching Hospital, Fuzhou 350014, China
| | - Huihua Hu
- Department of Medical Oncology, Fujian Provincial Cancer Hospital, Fujian Medical University Teaching Hospital, Fuzhou 350014, China
| | - Haipeng Xu
- Department of Medical Oncology, Fujian Provincial Cancer Hospital, Fujian Medical University Teaching Hospital, Fuzhou 350014, China
| | - Cheng Huang
- Department of Medical Oncology, Fujian Provincial Cancer Hospital, Fujian Medical University Teaching Hospital, Fuzhou 350014, China
| |
Collapse
|
24
|
Zhang H, Wang G, Yang X, Qiu M, Xu L. [Investigation of Gene Expression Profile of A549 Cells after Overexpression of GPC5
by High Throughput Transcriptome Sequencing]. ZHONGGUO FEI AI ZA ZHI = CHINESE JOURNAL OF LUNG CANCER 2016; 19:545-9. [PMID: 27561806 PMCID: PMC5972980 DOI: 10.3779/j.issn.1009-3419.2016.08.11] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Abstract
背景与目的 磷脂酰肌醇蛋白聚糖-5(glypican-5, GPC5)是一个重要的抑癌基因, 然而GPC5对肺腺癌细胞增殖能力和基因表达的影响目前研究甚少。本研究拟在肺腺癌A549细胞中过表达GPC5以研究细胞增殖能力和基因表达变化情况。 方法 通过慢病毒载体构建稳定过表达GPC5的A549细胞株, 通过Cell Counter Kit 8 (CCK8)、平板克隆和EdU实验检测细胞增殖能力; 通过高通量转录组测序研究基因表达变化。 结果 相对于空白载体组, CCK8实验发现过表达GPC5可以明显抑制A549细胞的增殖速率; 平板克隆实验结果显示, 过表达GPC5之后A549细胞克隆形成能力下降(181±17 vs 278±23);EdU染色结果显示过表达GPC5后阳性染色细胞比例下降。转录组测序结果提示过表达GPC5之后, 2, 108个基因表达发生明显变化, 其中具有正性调节细胞增殖作用的基因明显下调。 结论 过表达GPC5可以明显抑制肺腺癌细A549的增殖能力, 而且过表达GPC5后具有正性调节细胞增殖作用的基因表达下调。
Collapse
Affiliation(s)
- Haitian Zhang
- Department of Clinical Medicine, Xuzhou Medical University, Xuzhou 221004, China
| | - Guoxiang Wang
- Department of Cardiothoracic Surgery, Affiliated Hospital of Xuzhou Medical University, Xuzhou 221000, China
| | - Xin Yang
- Department of Oncology, the First People's Hospital of Changzhou, Changzhou 213003, China
| | - Mantang Qiu
- Department of Thoracic Surgery, Nanjing Medical University Affiliated Cancer Hospital, Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Cancer Institute of Jiangsu Province, Nanjing 210009, China
| | - Lin Xu
- Department of Thoracic Surgery, Nanjing Medical University Affiliated Cancer Hospital, Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Cancer Institute of Jiangsu Province, Nanjing 210009, China
| |
Collapse
|
25
|
Koo JW, Quintanilla-Dieck L, Jiang M, Liu J, Urdang ZD, Allensworth JJ, Cross CP, Li H, Steyger PS. Endotoxemia-mediated inflammation potentiates aminoglycoside-induced ototoxicity. Sci Transl Med 2016. [PMID: 26223301 DOI: 10.1126/scitranslmed.aac5546] [Citation(s) in RCA: 76] [Impact Index Per Article: 9.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/16/2023]
Abstract
The ototoxic aminoglycoside antibiotics are essential to treat severe bacterial infections, particularly in neonatal intensive care units. Using a bacterial lipopolysaccharide (LPS) experimental model of sepsis, we tested whether LPS-mediated inflammation potentiates cochlear uptake of aminoglycosides and permanent hearing loss in mice. Using confocal microscopy and enzyme-linked immunosorbent assays, we found that low-dose LPS (endotoxemia) greatly increased cochlear concentrations of aminoglycosides and resulted in vasodilation of cochlear capillaries without inducing paracellular flux across the blood-labyrinth barrier (BLB) or elevating serum concentrations of the drug. Additionally, endotoxemia increased expression of both serum and cochlear inflammatory markers. These LPS-induced changes, classically mediated by Toll-like receptor 4 (TLR4), were attenuated in TLR4-hyporesponsive mice. Multiday dosing with aminoglycosides during chronic endotoxemia induced greater hearing threshold shifts and sensory cell loss compared to mice without endotoxemia. Thus, endotoxemia-mediated inflammation enhanced aminoglycoside trafficking across the BLB and potentiated aminoglycoside-induced ototoxicity. These data indicate that patients with severe infections are at greater risk of aminoglycoside-induced hearing loss than previously recognized.
Collapse
Affiliation(s)
- Ja-Won Koo
- Oregon Hearing Research Center, Department of Otolaryngology, Oregon Health & Science University, 3181 Southwest Sam Jackson Park Road, Portland, OR 97239, USA. Department of Otorhinolaryngology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, 173-82 Kumiro, Bundang-gu, Seongnam 463-707, Republic of Korea
| | - Lourdes Quintanilla-Dieck
- Oregon Hearing Research Center, Department of Otolaryngology, Oregon Health & Science University, 3181 Southwest Sam Jackson Park Road, Portland, OR 97239, USA
| | - Meiyan Jiang
- Oregon Hearing Research Center, Department of Otolaryngology, Oregon Health & Science University, 3181 Southwest Sam Jackson Park Road, Portland, OR 97239, USA
| | - Jianping Liu
- Oregon Hearing Research Center, Department of Otolaryngology, Oregon Health & Science University, 3181 Southwest Sam Jackson Park Road, Portland, OR 97239, USA. Department of Otology and Skull Base Surgery, Eye Ear Nose and Throat Hospital, Fudan University, Shanghai 200031, China
| | - Zachary D Urdang
- Oregon Hearing Research Center, Department of Otolaryngology, Oregon Health & Science University, 3181 Southwest Sam Jackson Park Road, Portland, OR 97239, USA
| | - Jordan J Allensworth
- Oregon Hearing Research Center, Department of Otolaryngology, Oregon Health & Science University, 3181 Southwest Sam Jackson Park Road, Portland, OR 97239, USA
| | - Campbell P Cross
- Oregon Hearing Research Center, Department of Otolaryngology, Oregon Health & Science University, 3181 Southwest Sam Jackson Park Road, Portland, OR 97239, USA
| | - Hongzhe Li
- Oregon Hearing Research Center, Department of Otolaryngology, Oregon Health & Science University, 3181 Southwest Sam Jackson Park Road, Portland, OR 97239, USA
| | - Peter S Steyger
- Oregon Hearing Research Center, Department of Otolaryngology, Oregon Health & Science University, 3181 Southwest Sam Jackson Park Road, Portland, OR 97239, USA.
| |
Collapse
|
26
|
Li J, Wu X, Wang Z, Shen Z, Sun N, Zhu X. [Ionizing Radiation Reduces TKI Resistance Caused by T790M Mutation in NSCLC Cell Lines]. ZHONGGUO FEI AI ZA ZHI = CHINESE JOURNAL OF LUNG CANCER 2016; 18:475-80. [PMID: 26302343 PMCID: PMC6000229 DOI: 10.3779/j.issn.1009-3419.2015.08.02] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
背景与目的 以表皮生长因子受体(epidermal growth factor receptor, EGFR)为靶点的分子靶向治疗在非小细胞肺癌(non-small cell lung cancer, NSCLC)的治疗中发挥重要的作用。EGFR突变的患者对EGFR酪氨酸激酶抑制剂(EGFR-tyrosine kinase inhibitor, EGFR-TKI)治疗敏感、疗效显著,但无论近期疗效如何,患者最终都不可避免地产生耐药。大量研究证实,EGFR基因的二次突变(T790M)是患者耐药的主要原因。本研究旨在探讨电离辐射对NSCLC细胞株T790M突变所致EGFR-TKI耐药的影响。 方法 选择NSCLC细胞株H1975和H3255为研究对象,实时荧光定量PCR法检测两株细胞的突变状态、克隆形成实验观察两株细胞的放射敏感性,MTT法检测各处理组两株细胞对EGFR-TKI的抗药性。 结果 H1975为T790M+L858R双突变株、H3255是仅有L858R的单突变株;各处理组H1975及H3255的存活分数未见明显差异(P=0.952),提示T790M突变对NSCLC细胞株的放射敏感性无影响;2.5 Gy X线辐射组,H1975的IC50为(0.678, 2±0.373)μmol/L,较0 Gy对照组的(3.520±0.821)μmol/L明显下降,差异有统计学意义(P=0.008),H1975相较于H3255的抗药性也从85.9倍下降为39.2倍。 结论 电离辐射可降低NSCLC细胞株T790M突变所致的TKI耐药,本实验的研究结果为后续的体内和临床研究提供了研究依据;EGFR-TKI治疗期间联合放射治疗对克服T790M突变介导的耐药性有望成为一种有希望的治疗策略。
Collapse
Affiliation(s)
- Jing Li
- Department of Radiation Oncology, Jinling Hospital, Medical School of Nanjing University, Nanjing 210002, China
| | - Xinhu Wu
- Department of Radiation Oncology, Jinling Hospital, Medical School of Nanjing University, Nanjing 210002, China
| | - Zhen Wang
- Department of Radiation Oncology, Jinling Hospital, Medical School of Nanjing University, Nanjing 210002, China
| | - Zetian Shen
- Department of Radiation Oncology, Jinling Hospital, Medical School of Nanjing University, Nanjing 210002, China
| | - Ni Sun
- Department of Radiation Oncology, Jinling Hospital, Medical School of Nanjing University, Nanjing 210002, China
| | - Xixu Zhu
- Department of Radiation Oncology, Jinling Hospital, Medical School of Nanjing University, Nanjing 210002, China
| |
Collapse
|
27
|
Liu B, Du L, Xu C, Wang Y, Wang Q, Song Z, Sun X, Wang J, Liu Q. [Radiosensitization Induced by ANTP-SmacN7 Fusion Peptide in H460 Cell Line]. ZHONGGUO FEI AI ZA ZHI = CHINESE JOURNAL OF LUNG CANCER 2016; 19:241-6. [PMID: 27215450 PMCID: PMC5973049 DOI: 10.3779/j.issn.1009-3419.2016.05.01] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
背景与目的 肿瘤的辐射耐受制约了放疗疗效,第二个线粒体衍生的半胱氨酸蛋白酶激活剂(Second mitochondria-derived activator of caspase, Smac)蛋白类似物可明显提高辐射诱导的肿瘤细胞凋亡,有望成为新型肿瘤辐射增敏药物。本研究旨在探讨新型Smac蛋白类似物ANTP-SmacN7融合肽对肺癌细胞系H460的辐射增敏作用。 方法 合成ANTP-SmacN7融合肽,连接荧光素FITC以观察融合肽能否进入细胞。对数生长期H460细胞分为空白对照组、单纯照射组、ANTP-SmacN7组和照射联合ANTP-SmacN7组,单纯照射组给予0 Gy、2 Gy、4 Gy、6 Gy照射,照射联合ANTP-SmacN7组中ANTP-SmacN7的浓度为20 μmol/L,WST-1测定H460细胞的增殖。流式细胞仪测定细胞处理后24 h和48 h的细胞凋亡率。Western blot实验检测caspase3和cleaved caspase3的表达水平。 结果 ANTP-SmacN7融合能够顺利进入细胞,且能够增强H460细胞的辐射敏感性(F=25.1,P < 0.01,增敏比为1.86),照射联合ANTP-SmacN7可明显降低H460细胞的克隆形成率(χ2=45.2, P < 0.01; χ2=40.3, P < 0.01),提高cleaved caspase3的表达量,促进caspase3的活化,增加辐射诱导的细胞凋亡率。 结论 ANTP-SmacN7融合肽可明显提高H460细胞的辐射敏感性,作为一种新的Smac蛋白类似物有望用于肿瘤的辐射增敏治疗。
Collapse
Affiliation(s)
- Baona Liu
- Institute of Radiation Medicine of Chinese Academy of Medical Science and Peking Union Medical College, Tianjin Key Lab of Radiation and Molecular Nuclear Medicine, Tianjin 300192, China
| | - Liqing Du
- Institute of Radiation Medicine of Chinese Academy of Medical Science and Peking Union Medical College, Tianjin Key Lab of Radiation and Molecular Nuclear Medicine, Tianjin 300192, China
| | - Chang Xu
- Institute of Radiation Medicine of Chinese Academy of Medical Science and Peking Union Medical College, Tianjin Key Lab of Radiation and Molecular Nuclear Medicine, Tianjin 300192, China
| | - Yan Wang
- Institute of Radiation Medicine of Chinese Academy of Medical Science and Peking Union Medical College, Tianjin Key Lab of Radiation and Molecular Nuclear Medicine, Tianjin 300192, China
| | - Qin Wang
- Institute of Radiation Medicine of Chinese Academy of Medical Science and Peking Union Medical College, Tianjin Key Lab of Radiation and Molecular Nuclear Medicine, Tianjin 300192, China
| | - Zhiyi Song
- Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin 300120, China
| | - Xiaohui Sun
- Institute of Radiation Medicine of Chinese Academy of Medical Science and Peking Union Medical College, Tianjin Key Lab of Radiation and Molecular Nuclear Medicine, Tianjin 300192, China
| | - Jinhan Wang
- Institute of Radiation Medicine of Chinese Academy of Medical Science and Peking Union Medical College, Tianjin Key Lab of Radiation and Molecular Nuclear Medicine, Tianjin 300192, China
| | - Qiang Liu
- Institute of Radiation Medicine of Chinese Academy of Medical Science and Peking Union Medical College, Tianjin Key Lab of Radiation and Molecular Nuclear Medicine, Tianjin 300192, China
| |
Collapse
|
28
|
Li H, Wang Q, Zhang L, Bao H, Zhang H. [Regulation Mechanism of MTA3 in the Apoptosis of NSCLC Cells]. ZHONGGUO FEI AI ZA ZHI = CHINESE JOURNAL OF LUNG CANCER 2016; 18:610-5. [PMID: 26483332 PMCID: PMC6000090 DOI: 10.3779/j.issn.1009-3419.2015.10.02] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 12/04/2022]
Abstract
背景与目的 肿瘤转移基因(metastasis associated gene, MTA)是一个肿瘤候选基因家族, 主要包括MTA1、MTA2、MTA3, 已有的研究证实在不同肿瘤中MTA3发挥着相反的作用, 本研究旨在探讨MTA3在肺癌细胞中调控细胞凋亡方面的影响。 方法 应用Western blot方法和Real-time PCR方法检测肺癌细胞系A549和H157中MTA3的转染效率, 流式细胞仪方法检测上调/下调MTA3后肺癌细胞凋亡情况, Western blot方法检测下调MTA3后凋亡相关基因的表达。 结果 在肺癌细胞系A549和H157中干扰MTA3后则促进细胞凋亡, 同时引起凋亡相关蛋白Bax、Cleved-Caspase-3、p-PARP表达上调及Bcl-2表达下调。 结论 MTA3在肺癌细胞系A549和H157细胞中通过抑制凋亡相关基因的表达抑制细胞凋亡。
Collapse
Affiliation(s)
- Haiying Li
- Department of Pathology, College of Basic Medical Science, Xuzhou Medical College, Xuzhou 221000, China
| | - Qingling Wang
- Department of Pathology, College of Basic Medical Science, Xuzhou Medical College, Xuzhou 221000, China
| | - Lin Zhang
- Department of Pathology, College of Basic Medical Science, Xuzhou Medical College, Xuzhou 221000, China
| | - Haijun Bao
- Department of Pathology, College of Basic Medical Science, Xuzhou Medical College, Xuzhou 221000, China
| | - Heng Zhang
- Department of Pathology, College of Basic Medical Science, Xuzhou Medical College, Xuzhou 221000, China
| |
Collapse
|
29
|
Kan L, Zhang M, He P. [LRRC3B is Downregulated in Non-small Cell Lung Cancer and Connected with Cell Proliferation and Invasion]. ZHONGGUO FEI AI ZA ZHI = CHINESE JOURNAL OF LUNG CANCER 2016; 19:177-83. [PMID: 27118644 PMCID: PMC5999812 DOI: 10.3779/j.issn.1009-3419.2016.04.01] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
背景与目的 已有的研究表明:在许多恶性肿瘤细胞中,LRRC3B表达显著下调,被视为肿瘤抑制蛋白。然而,在非小细胞肺癌中它的表达模式和生物学作用缺乏研究。人类癌症微阵列的研究显示LRRC3B在乳腺癌和结肠直肠癌表达下调,提示LRRC3B参与致癌作用。本研究的目的是研究LRRC3B在非小细胞肺癌中的必到状态及其与肺癌增殖、侵袭和细胞周期间的相关性,探讨LRRC3B在调控肺癌细胞增殖、侵袭及细胞周期中的作用。 方法 应用Western blot和Realtime RT-PCR检测LRRC3B在几株肺癌细胞系中的mRNA和蛋白表达水平。应用MTT法检测对转染LRRC3B的A549和H460细胞系细胞增殖能力变化,应用集落形成实验以及细胞侵袭实验研究LRRC3B对细胞增殖和侵袭以及细胞周期进程的作用。肺癌细胞系H3255中转染LRRC3B siRAN验证LRRC3B对细胞的增殖以及侵袭能力和对细胞周期进程的影响。 结果 与正常NHBE细胞系相比,NSCLC细胞系中LRRC3B蛋白表达量显著下调,特别是H460、H358、HCC827以及A549。A549和H460细胞系转染LRRC3B后,细胞增殖和侵袭能力受到抑制。LRRC3B抑制细胞周期进程,并下调cyclin D1和MMP9的表达。H3255细胞中敲除LRRC3B,细胞增殖和侵袭能力显著增强,同时与细胞周期及侵袭能力相关的蛋白cyclin D1和MMP9表达略微上调。 结论 LRRC3B在肺癌细胞系中表达下调,而上调LRRC3B则能够抑制肺癌细胞增殖和侵袭能力,并抑制细胞周期进程,可能是未来肺癌治疗的一个新靶点。
Collapse
Affiliation(s)
- Liang Kan
- Department of Geriatrics, Shengjing Hospital of China Medical University, Shenyang 110004, China
| | - Meng Zhang
- Department of Geriatrics, Shengjing Hospital of China Medical University, Shenyang 110004, China
| | - Ping He
- Department of Geriatrics, Shengjing Hospital of China Medical University, Shenyang 110004, China
| |
Collapse
|
30
|
Huang W, Wang Y, Zhu H, Wu Y, Xie X, Wang D. [Solasonine-induced Apoptosis in Lung Cancer Cell Line H446 and Its Mechanism]. ZHONGGUO FEI AI ZA ZHI = CHINESE JOURNAL OF LUNG CANCER 2016; 18:416-21. [PMID: 26182866 PMCID: PMC6000244 DOI: 10.3779/j.issn.1009-3419.2015.07.05] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
背景与目的 肺癌的发病率和病死率都急剧上升,小细胞肺癌首选化疗而不能手术,而中医药副作用小,有研究表明中药澳洲茄碱具有抗肿瘤活性作用。本研究旨在探讨澳洲茄碱对肺癌细胞株H446凋亡作用的影响。 方法 用CCK8试剂盒筛选药物作用的合适浓度和时间,以药物浓度为0 μmol/L、3.4 μmol/L、6.8 μmol/L、13.6 μmol/L分4组,作用于H446细胞24 h后,倒置显微镜观察细胞形态的变化,DAPI核染观察细胞核变化,流式细胞术检测药物对细胞凋亡的影响,Western blot检测凋亡相关蛋白BCL2、BAX、CASP3表达的变化。 结果 澳洲茄碱可降低H446细胞的存活率,抑制其增殖,具有剂量相关性,存活率可降低至16.77%(P < 0.001),最高凋亡率为44.62%(P < 0.001);H446有明显的细胞凋亡形态学变化;Western blot显示凋亡相关蛋白BAX、CASP3表达上调(P < 0.05),凋亡抑制基因蛋白BCL2表达下调(P < 0.05)。 结论 澳洲茄碱可抑制H446细胞的增殖,上调促凋亡相关蛋白表达,下调抑凋亡蛋白表达,从而促进细胞的凋亡。
Collapse
Affiliation(s)
- Wensi Huang
- Affiliated Hospital of Jiangsu University, Zhenjiang 212000, China
| | - Ying Wang
- Affiliated Hospital of Jiangsu University, Zhenjiang 212000, China
| | - Haitao Zhu
- Affiliated Hospital of Jiangsu University, Zhenjiang 212000, China
| | - Yingying Wu
- Affiliated Hospital of Jiangsu University, Zhenjiang 212000, China
| | - Xiaodong Xie
- Affiliated Hospital of Jiangsu University, Zhenjiang 212000, China
| | - Dongqing Wang
- Affiliated Hospital of Jiangsu University, Zhenjiang 212000, China
| |
Collapse
|
31
|
Zhang X, Liu G, Liu H, Ma T. [Sequence-dependent Effect of Triptolide with Gefitinib on the Proliferation
and Apoptosis of Lung Adenocarcinoma Cell H1975]. ZHONGGUO FEI AI ZA ZHI = CHINESE JOURNAL OF LUNG CANCER 2015; 18:599-609. [PMID: 26483331 PMCID: PMC6000088 DOI: 10.3779/j.issn.1009-3419.2015.10.01] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
背景与目的 表皮生长因子受体(epidermal growth factor receptor, EGFR)酪氨酸激酶抑制剂(tyrosine kinase inhibitors, TKIs)被用于治疗进展性晚期非小细胞肺癌(non-small cell lung cancer, NSCLC), 然而最初接受TKIs治疗有反应的患者, 大都会在10个月左右出现获得性耐药。报告称EGFR基因T790M的突变是产生获得性耐药的主要原因, 比例约占50%。本研究旨在探索雷公藤甲素(triptolide, TP)和吉非替尼序贯应用对肺腺癌细胞H1975细胞增殖和凋亡通路的作用。 方法 MTT法检测细胞的增殖。等效线图法和联合指数(combination index, CI)法评估雷公藤甲素和吉非替尼序贯作用的效价。流式细胞术检测细胞凋亡和周期分布, Hoechest 33258染色法检测凋亡形态。化学比色发光法检测Caspases的活性。 结果 等效线图法和联合指数法均显示雷公藤甲素序贯吉非替尼组较其他序贯作用组明显抑制了细胞增殖, 增加了细胞的凋亡。细胞周期分布实验结果显示与吉非替尼序贯雷公藤甲素组主要把细胞抑制在G0/G1期相比较, 雷公藤甲素序贯吉非替尼组主要把细胞抑制在G2/M期。在肺腺癌H1975中, 所有序贯模型组都主要通过活化Caspase-9/Caspase-3来诱导激活细胞凋亡通路。 结论 先用雷公藤甲素再用吉非替尼治疗模式可能是克服T790M突变耐药的一个新选择。
Collapse
Affiliation(s)
- Xinyu Zhang
- Department of Pharmacy, Bengbu Medical College, Bengbu 233000, China
| | - Guiyang Liu
- Department of Pharmacy, the Affiliated Hospital of Chinese PLA Hospital, Beijing 100853, China
| | - Hao Liu
- Department of Pharmacy, Bengbu Medical College, Bengbu 233000, China
| | - Tao Ma
- Department of Pharmacy, Bengbu Medical College, Bengbu 233000, China
| |
Collapse
|
32
|
El Zowalaty ME, Al Thani AA, Webster TJ, El Zowalaty AE, Schweizer HP, Nasrallah GK, Marei HE, Ashour HM. Pseudomonas aeruginosa: arsenal of resistance mechanisms, decades of changing resistance profiles, and future antimicrobial therapies. Future Microbiol 2015; 10:1683-706. [PMID: 26439366 DOI: 10.2217/fmb.15.48] [Citation(s) in RCA: 88] [Impact Index Per Article: 9.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2023] Open
Abstract
Antimicrobial resistance is one of the most serious public health issues facing humans since the discovery of antimicrobial agents. The frequent, prolonged, and uncontrolled use of antimicrobial agents are major factors in the emergence of antimicrobial-resistant bacterial strains, including multidrug-resistant variants. Pseudomonas aeruginosa is a leading cause of nosocomial infections. The abundant data on the increased resistance to antipseudomonal agents support the need for global action. There is a paucity of new classes of antibiotics active against P. aeruginosa. Here, we discuss recent antibacterial resistance profiles and mechanisms of resistance by P. aeruginosa. We also review future potential methods for controlling antibiotic-resistant bacteria, such as phage therapy, nanotechnology and antipseudomonal vaccines.
Collapse
Affiliation(s)
- Mohamed E El Zowalaty
- Department of Microbiology & Immunology, Emory University School of Medicine, Atlanta, GA 30322, USA.,BioMedical Research Center, Qatar University, Doha, PO Box 2713, Qatar
| | - Asmaa A Al Thani
- BioMedical Research Center, Qatar University, Doha, PO Box 2713, Qatar.,Department of Health Sciences, College of Arts and Sciences, Qatar University, Doha 2713, Qatar
| | - Thomas J Webster
- Department of Chemical Engineering, Northeastern University, Boston, MA 02018, USA.,Center of Excellence for Advanced Materials Research, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia
| | - Ahmed E El Zowalaty
- Department of Physiology & Pharmacology, College of Veterinary Medicine, University of Georgia, Athens, GA 30602, USA.,Interdisciplinary Toxicology Program, University of Georgia, Athens, GA 30602, USA
| | - Herbert P Schweizer
- Department of Molecular Genetics & Microbiology, College of Medicine, University of Florida, Gainesville, FL 32611, USA.,Emerging Pathogens Institute, Institute for Therapeutic Innovation, University of Florida Gainesville, FL 32611, USA
| | - Gheyath K Nasrallah
- BioMedical Research Center, Qatar University, Doha, PO Box 2713, Qatar.,Department of Health Sciences, College of Arts and Sciences, Qatar University, Doha 2713, Qatar
| | - Hany E Marei
- BioMedical Research Center, Qatar University, Doha, PO Box 2713, Qatar
| | - Hossam M Ashour
- Department of Microbiology & Immunology, Faculty of Pharmacy, Cairo University, Egypt.,Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy & Health Sciences, Wayne State University, Detroit, MI, USA
| |
Collapse
|
33
|
Lambert R, Srodulski S, Peng X, Margulies KB, Despa F, Despa S. Intracellular Na+ Concentration ([Na+]i) Is Elevated in Diabetic Hearts Due to Enhanced Na+-Glucose Cotransport. J Am Heart Assoc 2015; 4:e002183. [PMID: 26316524 PMCID: PMC4599504 DOI: 10.1161/jaha.115.002183] [Citation(s) in RCA: 74] [Impact Index Per Article: 8.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
Background Intracellular Na+ concentration ([Na+]i) regulates Ca2+ cycling, contractility, metabolism, and electrical stability of the heart. [Na+]i is elevated in heart failure, leading to arrhythmias and oxidative stress. We hypothesized that myocyte [Na+]i is also increased in type 2 diabetes (T2D) due to enhanced activity of the Na+–glucose cotransporter. Methods and Results To test this hypothesis, we used myocardial tissue from humans with T2D and a rat model of late-onset T2D (HIP rat). Western blot analysis showed increased Na+–glucose cotransporter expression in failing hearts from T2D patients compared with nondiabetic persons (by 73±13%) and in HIP rat hearts versus wild-type (WT) littermates (by 61±8%). [Na+]i was elevated in HIP rat myocytes both at rest (14.7±0.9 versus 11.4±0.7 mmol/L in WT) and during electrical stimulation (17.3±0.8 versus 15.0±0.7 mmol/L); however, the Na+/K+-pump function was similar in HIP and WT cells, suggesting that higher [Na+]i is due to enhanced Na+ entry in diabetic hearts. Indeed, Na+ influx was significantly larger in myocytes from HIP versus WT rats (1.77±0.11 versus 1.29±0.06 mmol/L per minute). Na+–glucose cotransporter inhibition with phlorizin or glucose-free solution greatly reduced Na+ influx in HIP myocytes (to 1.20±0.16 mmol/L per minute), whereas it had no effect in WT cells. Phlorizin also significantly decreased glucose uptake in HIP myocytes (by 33±9%) but not in WT, indicating an increased reliance on the Na+–glucose cotransporter for glucose uptake in T2D hearts. Conclusions Myocyte Na+–glucose cotransport is enhanced in T2D, which increases Na+ influx and causes Na+ overload. Higher [Na+]i may contribute to arrhythmogenesis and oxidative stress in diabetic hearts.
Collapse
Affiliation(s)
- Rebekah Lambert
- Department of Pharmacology and Nutritional Sciences, University of Kentucky, Lexington, KY (R.L., S.S., X.P., F.D., S.D.)
| | - Sarah Srodulski
- Department of Pharmacology and Nutritional Sciences, University of Kentucky, Lexington, KY (R.L., S.S., X.P., F.D., S.D.)
| | - Xiaoli Peng
- Department of Pharmacology and Nutritional Sciences, University of Kentucky, Lexington, KY (R.L., S.S., X.P., F.D., S.D.)
| | - Kenneth B Margulies
- Cardiovascular Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA (K.B.M.)
| | - Florin Despa
- Department of Pharmacology and Nutritional Sciences, University of Kentucky, Lexington, KY (R.L., S.S., X.P., F.D., S.D.)
| | - Sanda Despa
- Department of Pharmacology and Nutritional Sciences, University of Kentucky, Lexington, KY (R.L., S.S., X.P., F.D., S.D.)
| |
Collapse
|
34
|
Chai S, An W, Guo L, Jiang L, Gao Z, Li S. [Effect of Long Non-coding RNA SPRY4-IT1 on Invasion and Migration of A549 Cells]. ZHONGGUO FEI AI ZA ZHI = CHINESE JOURNAL OF LUNG CANCER 2015; 18:487-92. [PMID: 26302345 PMCID: PMC6000226 DOI: 10.3779/j.issn.1009-3419.2015.08.07] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
背景与目的 人长链非编码RNA基因的异常表达与多种肿瘤有关。本研究旨在探讨人长链非编码RNA基因SPRY4-ITl对肺癌细胞A549侵袭和迁移能力的影响及机制。 方法 将SPRY4-ITl转染入肺癌A549细胞系,采用RT-PCR方法检测重组质粒在细胞中表达水平比较;采用MTT和Transwell检测A549细胞侵袭和迁移能力的变化,采用Western blot方法检测SPRY4-ITl对MMP-2和MMP-9蛋白的影响。 结果 转染pcDNA3.1-SPRY4-ITl细胞划痕两侧细胞间距较转染pcDNA3.1细胞明显变窄,其穿膜细胞数为(207 ± 34)个/视野,相比对照组明显增多(P < 0.05),且转染pcDNA3.1-SPRY4-ITl细胞中的基质金属蛋白酶(matrix metalloproteinase, MMP)-2及MMP-9蛋白表达较转染空质粒组均有升高。 结论 在肺癌A549细胞中过表达SPRY4-IT1可增强细胞的侵袭、迁移能力,且细胞内MMP-2及MMP-9表达升高,提示SPRY4-IT1可能通过调控MMP影响肺癌的侵袭和转移能力。
Collapse
Affiliation(s)
- Song Chai
- Cancer Center, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, China
| | - Wenting An
- Cancer Center, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, China
| | - Lili Guo
- Cancer Center, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, China
| | - Le Jiang
- Cancer Center, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, China
| | - Zhisong Gao
- Cancer Center, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, China
| | - Shujun Li
- Cancer Center, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, China
| |
Collapse
|
35
|
Jiang G, Li L, Wu X, Dong S, Tong X. [Influence of Berberine on Cisplatin Antineoplastic Effect in A549 Cells]. ZHONGGUO FEI AI ZA ZHI = CHINESE JOURNAL OF LUNG CANCER 2015; 18:481-6. [PMID: 26302344 PMCID: PMC6000235 DOI: 10.3779/j.issn.1009-3419.2015.08.03] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Abstract
背景与目的 以顺铂为基础的化疗方案是晚期非小细胞肺癌的一线化疗方案,但是由于顺铂的不良反应严重及耐药性的产生均限制了它的临床应用,本研究采用联合用药的方式观察黄连素对顺铂抗肿瘤作用的影响,并探讨其可能机制。 方法 分别观察黄连素对肺腺癌细胞A549细胞中总Cx43蛋白、细胞膜Cx43蛋白的表达以及细胞缝隙连接功能的改变,通过标准细胞集落克隆实验观察黄连素对顺铂细胞毒性的影响;并观察PKC激酶的表达。 结果 黄连素在0 μM-10 μM浓度范围内对细胞无毒性,通过增加细胞内总Cx43蛋白和胞膜Cx43蛋白的表达而增强细胞缝隙连接功能;这种作用与PKC的活性被抑制相关,抑制PKC活性可以进一步增加顺铂对A549细胞的毒性作用。 结论 黄连素可通过增加A549细胞的缝隙连接功能而明显增强顺铂的细胞毒性。
Collapse
Affiliation(s)
- Guojun Jiang
- Faculty of Pharmacy, Bengbu Medical College/Anhui Engineering Technology Research Center of Biochemical Pharmaceuticals, Bengbu 233030, China
| | - Li Li
- Faculty of Pharmacy, Bengbu Medical College/Anhui Engineering Technology Research Center of Biochemical Pharmaceuticals, Bengbu 233030, China
| | - Xiaoxiang Wu
- Faculty of Pharmacy, Bengbu Medical College/Anhui Engineering Technology Research Center of Biochemical Pharmaceuticals, Bengbu 233030, China
| | - Shuying Dong
- Faculty of Pharmacy, Bengbu Medical College/Anhui Engineering Technology Research Center of Biochemical Pharmaceuticals, Bengbu 233030, China
| | - Xuhui Tong
- Faculty of Pharmacy, Bengbu Medical College/Anhui Engineering Technology Research Center of Biochemical Pharmaceuticals, Bengbu 233030, China
| |
Collapse
|
36
|
Jiang M, Steyger PS. An evaluation of US patent 2015065565 (A1) for a new class of SGLT2 inhibitors for treatment 1 of type II diabetes mellitus. Expert Opin Ther Pat 2015; 25:1349-52. [PMID: 26291462 DOI: 10.1517/13543776.2015.1076392] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
INTRODUCTION Type 2 diabetes mellitus (T2DM) is a growing and serious global health problem. Pharmacological inhibition of the sodium-glucose cotransporter-2 (SGLT2; SLC5A2) increases urinary glucose excretion, decreasing plasma glucose levels in an insulin-independent manner. Agents that inhibit SGLT2 have recently become available for clinical therapy of T2DM. AREAS COVERED The patent claims a new class of SGLT2 inhibitors: derivatives of dioxa-bicyclo[3.2.1]octane-2,3,4-triol (including ertugliflozin; PF-04971729). The invention describes the design, synthesis and pharmacological tests related to ertugliflozin, which could ultimately lead to efficacious therapy for T2DM alone or in combination with other anti-diabetic agents. EXPERT OPINION Ertugliflozin is likely to be of great clinical significance in the near future. Continued analysis of ertugliflozin derivatives to now validate safe and efficacious treatment of T2DM in a larger number of clinical subjects over an extended period is needed to further support clinical utility. Identification, and discussion, of likely contra-indications is also needed.
Collapse
Affiliation(s)
- Meiyan Jiang
- a Oregon Health & Science University, Otolaryngology, Oregon Hearing Research Center , 3181 SW Sam Jackson Park Road, Portland, USA
| | - Peter S Steyger
- a Oregon Health & Science University, Otolaryngology, Oregon Hearing Research Center , 3181 SW Sam Jackson Park Road, Portland, USA
| |
Collapse
|
37
|
Wu D, Jin G, Zhao D, Zhang Y, Zhao J, Yu H. [Methodology of Establishing and Identifying NCI-H2228/Crizotinib-resistant Cell Lines In Vitro]. ZHONGGUO FEI AI ZA ZHI = CHINESE JOURNAL OF LUNG CANCER 2015; 18:330-9. [PMID: 26104888 PMCID: PMC5999905 DOI: 10.3779/j.issn.1009-3419.2015.06.02] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
背景与目的 小分子靶向药物发生耐药的机制及寻找克服耐药的手段是目前提高临床疗效需要迫切解决的问题。本研究探讨采用不同方法建立对Crizotinib耐药的非小细胞肺癌NCI-H2228/Crizotinib细胞株的可行性及鉴定分析,为深入研究Crizotinib耐药发生的机制并寻找克服耐药的手段提供实验基础和理论依据。 方法 采用逐步增加药物浓度和化学诱变剂处理NCI-H2228细胞,诱导细胞对Crizotinib耐药。MTT法检测亲本细胞和耐药细胞的50%抑制浓度(50% inhibitory concentration, IC50)和群体倍增时间。RT-PCR和Western blot实验检测棘皮动物微管相关蛋白样4-间变性淋巴瘤激酶(echinoderm microtubule-associated protein like 4-anaplastic lymph kinase, EML4-ALK)基因表达。对耐药细胞和亲本细胞的EML4-ALK基因全长测序并对比分析发生耐药的机制。 结果 逐步增加药物浓度的方法耗时过长,细胞恢复生长缓慢,不能有效诱导NCI-H2228细胞对Crizotinib耐药;化学诱变剂ENU可以在短时间内诱导NCI-H2228细胞对Crizotinib耐药[IC50=(3.810±1.100)μmol/L,P=0.002, 9,vs亲本细胞]。耐药细胞EML4-ALK基因发生点突变的频率高于亲本细胞。 结论 化学诱变剂诱导细胞耐药操作简便,可有效缩短实验流程,为深入研究耐药发生机制,寻找克服靶向药物耐药的手段提供了前期技术方法和实验依据。
Collapse
Affiliation(s)
- Di Wu
- Tumor Center, No.1 Hospital of Jilin University, Changchun 130012, China
| | - Guihua Jin
- School of Life Sciences, Northeast Normal University, Changchun 130024, China
| | - Dawei Zhao
- Department of Breast Tumor, Jilin Province Tumor Hospital, Changchun 130012, China
| | - Yue Zhang
- School of Life Sciences, Northeast Normal University, Changchun 130024, China
| | - Jing Zhao
- Key Laboratory for Zoonosis Research, Ministry of Education, Institute of Zoonosis, Jilin University, Changchun 130062, China
| | - Hong Yu
- Cell Biology Laboratory, Jilin Province Tumor Institute, Changchun 130012, China
| |
Collapse
|
38
|
Zhang Y, Chen Y, Ni W, Guo L, Lu X, Liu L, Li W, Sun S, Wang L, Li H. Dynamic expression of Lgr6 in the developing and mature mouse cochlea. Front Cell Neurosci 2015; 9:165. [PMID: 26029045 PMCID: PMC4428082 DOI: 10.3389/fncel.2015.00165] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/29/2014] [Accepted: 04/14/2015] [Indexed: 11/13/2022] Open
Abstract
The Wnt/β-catenin signaling pathway plays important roles in mammalian inner ear development. Lgr5, one of the downstream target genes of the Wnt/β-catenin signaling pathway, has been reported to be a marker for inner ear hair cell progenitors. Lgr6 shares approximately 50% sequence homology with Lgr5 and has been identified as a stem cell marker in several organs. However, the detailed expression profiles of Lgr6 have not yet been investigated in the mouse inner ear. Here, we first used Lgr6-EGFP-Ires-CreERT2 mice to examine the spatiotemporal expression of Lgr6 protein in the cochlear duct during embryonic and postnatal development. Lgr6-EGFP was first observed in one row of prosensory cells in the middle and basal turn at embryonic day 15.5 (E15.5). From E18.5 to postnatal day 3 (P3), the expression of Lgr6-EGFP was restricted to the inner pillar cells (IPCs). From P7 to P15, the Lgr6-EGFP expression level gradually decreased in the IPCs and gradually increased in the inner border cells (IBCs). At P20, Lgr6-EGFP was only expressed in the IBCs, and by P30 Lgr6-EGFP expression had completely disappeared. Next, we demonstrated that Wnt/β-catenin signaling is required to maintain the Lgr6-EGFP expression in vitro. Finally, we demonstrated that the Lgr6-EGFP-positive cells isolated by flow cytometry could differentiate into myosin 7a-positive hair cells after 10 days in-culture, and this suggests that the Lgr6-positive cells might serve as the hair cell progenitor cells in the cochlea.
Collapse
Affiliation(s)
- Yanping Zhang
- Research Center, Affiliated Eye and ENT Hospital of Fudan University Shanghai, China ; Key Laboratory of Hearing Medicine, Ministry of Health, Affiliated Eye and ENT Hospital of Fudan University Shanghai, China ; Institutes of Biomedical Sciences, Fudan University Shanghai, China
| | - Yan Chen
- Research Center, Affiliated Eye and ENT Hospital of Fudan University Shanghai, China ; Key Laboratory of Hearing Medicine, Ministry of Health, Affiliated Eye and ENT Hospital of Fudan University Shanghai, China
| | - Wenli Ni
- Department of Otorhinolaryngology, Affiliated Eye and ENT Hospital of Fudan University Shanghai, China
| | - Luo Guo
- Research Center, Affiliated Eye and ENT Hospital of Fudan University Shanghai, China ; Key Laboratory of Hearing Medicine, Ministry of Health, Affiliated Eye and ENT Hospital of Fudan University Shanghai, China
| | - Xiaoling Lu
- Department of Otorhinolaryngology, Affiliated Eye and ENT Hospital of Fudan University Shanghai, China
| | - Liman Liu
- Key Laboratory of Hearing Medicine, Ministry of Health, Affiliated Eye and ENT Hospital of Fudan University Shanghai, China
| | - Wen Li
- Research Center, Affiliated Eye and ENT Hospital of Fudan University Shanghai, China ; Key Laboratory of Hearing Medicine, Ministry of Health, Affiliated Eye and ENT Hospital of Fudan University Shanghai, China
| | - Shan Sun
- Research Center, Affiliated Eye and ENT Hospital of Fudan University Shanghai, China ; Key Laboratory of Hearing Medicine, Ministry of Health, Affiliated Eye and ENT Hospital of Fudan University Shanghai, China
| | - Lei Wang
- Institutes of Biomedical Sciences, Fudan University Shanghai, China
| | - Huawei Li
- Key Laboratory of Hearing Medicine, Ministry of Health, Affiliated Eye and ENT Hospital of Fudan University Shanghai, China ; Department of Otorhinolaryngology, Affiliated Eye and ENT Hospital of Fudan University Shanghai, China ; The State Key Laboratory of Medical Neurobiology, The Institutes of Brain Science and the Collaborative Innovation Center for Brain Science, Fudan University Shanghai, China
| |
Collapse
|
39
|
Uptake of fluorescent gentamicin by peripheral vestibular cells after systemic administration. PLoS One 2015; 10:e0120612. [PMID: 25793391 PMCID: PMC4368668 DOI: 10.1371/journal.pone.0120612] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2014] [Accepted: 02/04/2015] [Indexed: 11/28/2022] Open
Abstract
Objective In addition to cochleotoxicity, systemic aminoglycoside pharmacotherapy causes vestibulotoxicity resulting in imbalance and visual dysfunction. The underlying trafficking routes of systemically-administered aminoglycosides from the vasculature to the vestibular sensory hair cells are largely unknown. We investigated the trafficking of systemically-administered gentamicin into the peripheral vestibular system in C56Bl/6 mice using fluorescence-tagged gentamicin (gentamicin-Texas-Red, GTTR) imaged by scanning laser confocal microscopy to determine the cellular distribution and intensity of GTTR fluorescence in the three semicircular canal cristae, utricular, and saccular maculae at 5 time points over 4 hours. Results Low intensity GTTR fluorescence was detected at 0.5 hours as both discrete puncta and diffuse cytoplasmic fluorescence. The intensity of cytoplasmic fluorescence peaked at 3 hours, while punctate fluorescence was plateaued after 3 hours. At 0.5 and 1 hour, higher levels of diffuse GTTR fluorescence were present in transitional cells compared to hair cells and supporting cells. Sensory hair cells typically exhibited only diffuse cytoplasmic fluorescence at all time-points up to 4 hours in this study. In contrast, non-sensory cells rapidly exhibited both intense fluorescent puncta and weaker, diffuse fluorescence throughout the cytosol. The numbers and size of fluorescent puncta in dark cells and transitional cells increased over time. There is no preferential GTTR uptake by the five peripheral vestibular organs’ sensory cells. Control vestibular tissues exposed to Dulbecco’s phosphate-buffered saline or hydrolyzed Texas Red had negligible fluorescence. Conclusions All peripheral vestibular cells rapidly take up systemically-administered GTTR, reaching peak intensity 3 hours after injection. Sensory hair cells exhibited only diffuse fluorescence, while non-sensory cells displayed both diffuse and punctate fluorescence. Transitional cells may act as a primary pathway for trafficking of systemic GTTR from the vasculature to endolymph prior to entering hair cells.
Collapse
|